Trials / Completed
CompletedNCT01014507
Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
Randomisierte Phase II Studie Zum Einsatz Von Goserelin Und Oralen Kontrazeptiva Zur Reduktion Ovarieller Toxizitäten während Zytostatischer Primärtherapie Bei Fertilen Patientinnen Mit Hodgkin Lymphom in Fortgeschrittenen Stadien
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 8 cycles BEACOPPesc plus oral contraceptive | |
| DRUG | 8 cycles BEACOPPesc plus Goserelin |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-11-17
- Last updated
- 2012-06-25
Source: ClinicalTrials.gov record NCT01014507. Inclusion in this directory is not an endorsement.